Literature DB >> 18765111

Possible malignancy after cytology analysis in a 45-year-old man.

Mark Soloway1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18765111     DOI： 10.1007/s11934-008-0032-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  8 in total

1.  Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.

Authors:  L Bubendorf; B Grilli; G Sauter; M J Mihatsch; T C Gasser; P Dalquen
Journal:  Am J Clin Pathol       Date:  2001-07       Impact factor: 2.493

2.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

Authors:  K C Halling; W King; I A Sokolova; R G Meyer; H M Burkhardt; A C Halling; J C Cheville; T J Sebo; S Ramakumar; C S Stewart; S Pankratz; D J O'Kane; S A Seelig; M M Lieber; R B Jenkins
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

Review 3.  Molecular markers in bladder cancer: a critical appraisal.

Authors:  Badrinath R Konety
Journal:  Urol Oncol       Date:  2006 Jul-Aug       Impact factor: 3.498

4.  Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.

Authors:  Brian J Yoder; Marek Skacel; Ryan Hedgepeth; Denise Babineau; James C Ulchaker; Louis S Liou; Jennifer A Brainard; Charles V Biscotti; J Stephen Jones; Raymond R Tubbs
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

5.  Long-term outcome of hematuria home screening for bladder cancer in men.

Authors:  Edward M Messing; Ralph Madeb; Terry Young; Kennedy W Gilchrist; Lora Bram; E Barry Greenberg; John D Wegenke; Laura Stephenson; Jason Gee; Changyong Feng
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

6.  UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.

Authors:  Paula M J Moonen; Gerard F M Merkx; Pim Peelen; Herbert F M Karthaus; Dominique F C M Smeets; J Alfred Witjes
Journal:  Eur Urol       Date:  2006-10-30       Impact factor: 20.096

7.  Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.

Authors:  Michael F Sarosdy; Paul Schellhammer; Gary Bokinsky; Paul Kahn; Roberto Chao; Lawrence Yore; Joseph Zadra; Daniel Burzon; Gerald Osher; Julia A Bridge; Steven Anderson; Sonny L Johansson; Michael Lieber; Mark Soloway; Kerry Flom
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

8.  The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.

Authors:  Sigurdur Gudjónsson; Björn L Isfoss; Kerstin Hansson; Anna-Maria Domanski; Janina Warenholt; Wolfgang Soller; Lena-Maria Lundberg; Fredrik Liedberg; Magnus Grabe; Wiking Månsson
Journal:  Eur Urol       Date:  2007-12-07       Impact factor: 20.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.